Nature medicine
External trigeminal nerve stimulation in youth with ADHD: a randomized, sham-controlled, phase 2b trial.
Aldo Alberto Conti, Natali Bozhilova, Irem Ece Eraydin, Dominic Stringer, Lena Johansson, Robert Marhenke, Andrea Bilbow, Sahid El Masri, Joshua Hyde, Giovanni Giaroli, Holan Liang, Federico Fiori, Mitul Ashok Mehta, Paramala Santosh, Ben Carter
Published: 202610.1038/s41591-025-04075-x
Abstract
External trigeminal nerve stimulation (TNS) received US Food and Drug Administration clearance in 2019 as the first device-based, non-pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD), based on a small pilot sham-controlle…
Preview only. Read the full abstract at the source